News

News Board

News Board

  • SJL Partners acquires 3% stake in Celltrion Holdings [The Investor] 2018.10.09
  • A newly established private equity fund led by a former JP Morgan Korea chief has acquired a 3 percent stake in Celltrion Holdings, becoming the second-largest shareholder of the unlisted holding firm that controls biosimilar drug maker Celltrion Group.  


    MORE 관련기사 보러가기